Rosell Institute for Microbiome and Probiotics

The Rosell Institute for Microbiome and Probiotics is the research and development center of Lallemand Health Solutions, specializing in the study of the human microbiome and the development of probiotic solutions. Founded originally in 1934 and later integrated into Lallemand, the institute focuses on clinical research to validate the efficacy of specific probiotic strains in areas such as the gut-brain axis, immunity, and metabolic health. They offer a comprehensive range of services from strain selection and characterization to pilot-scale production and clinical trial management. The institute is recognized for pioneering the first clinical study on the gut-brain axis with its proprietary Probio'Stick formulation.